/wion/media/agency_attachments/2024/12/26/2024-12-26t112006978z-wion-white-logo-for-website-2-1.png){kind=logo}
/wion/media/agency_attachments/2024/12/13/2024-12-13t071548098z-wionlogo.webp)
European drug regulators are undertaking review of rare blood clots in four people in the United States of America who have received Johnson & Johnson COVID-19 vaccine.
Johnson & Johnson vaccine review follows blood clot cases
Advertisment